[{"address1": "2-9 Kanda-Tsukasamachi", "address2": "Chiyoda-ku", "city": "Tokyo", "zip": "101-0048", "country": "Japan", "phone": "81 3 6717 1410", "website": "https://www.otsuka.com", "industry": "Drug Manufacturers\u2014General", "sector": "Healthcare", "longBusinessSummary": "Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement instruments, nutritional products, vehicle headlight testers, synthetic resin molded products, paper products, and insecticide and toiletry products. In addition, the company offers IT solution services; adhesive tapes; flaky titanate and compounds; IV solutions; infusion and clinical nutrition products; hydrazine; plant-based food products; reinsurance underwriting services; wine; stable isotopes; food supplements; urinary tract health products; software and services for management of mental healthcare systems; anticancer drugs; terracess; bio-pesticides; dietetic food products; spring and mineral water; and polyolefin foams. Further, it engages in the warehousing and transport, medical device operational management, shared service, environmental health management, and venture capital and incubation businesses; rental of medical devices and related products; purchase and sale of agricultural products; import and export trading business; tuberculosis research and development activities; manufacturing and development of xenotransplantation products; and processing and marketing of functional films, as well as planning, design, production, and construction of ceramic boards and arts, ceramic walls, reliefs, terracotta, ceramic OT and portraits, and ceramic sign boards; and operation of travel agency, and Hotel Ridge and California Table. Otsuka Holdings Co., Ltd. was founded in 1921 and is headquartered in Tokyo, Japan.", "fullTimeEmployees": 34388, "companyOfficers": [{"maxAge": 1, "name": "Mr. Tatsuo  Higuchi", "age": 73, "title": "CEO, President & Representative Director", "yearBorn": 1950, "fiscalYear": 2022, "totalPay": 1534624, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Makoto  Inoue", "age": 65, "title": "COO & Representative Director", "yearBorn": 1958, "fiscalYear": 2022, "totalPay": 805504, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Yoshiro  Matsuo", "age": 63, "title": "Executive Deputy President & Executive Director", "yearBorn": 1960, "fiscalYear": 2022, "totalPay": 652736, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Masayuki  Kobayashi", "age": 57, "title": "Executive Director", "yearBorn": 1966, "fiscalYear": 2022, "totalPay": 784672, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Yuko  Makino", "age": 62, "title": "CFO & Executive Director", "yearBorn": 1961, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Tomohiro  Emura Ph.D.", "title": "Vice President of Investor Relations, Public Relations & Sustainability Promotion", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Akiko  Ryu", "title": "Senior VP & Director of Human Resource Planning Department", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Noriko  Tojo", "age": 59, "title": "Executive Director", "yearBorn": 1964, "fiscalYear": 2022, "totalPay": 499968, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Shuichi  Takagi", "age": 57, "title": "Executive Director", "yearBorn": 1966, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Chiaki  Sakurai", "title": "Senior Vice President of Nutraceutical Business, Global Strategy & Planning Headquarters", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 2, "previousClose": 31.17, "open": 31.86, "dayLow": 31.14, "dayHigh": 31.89, "regularMarketPreviousClose": 31.17, "regularMarketOpen": 31.86, "regularMarketDayLow": 31.14, "regularMarketDayHigh": 31.89, "dividendRate": 0.4, "dividendYield": 0.0128999995, "exDividendDate": 1719532800, "payoutRatio": 0.4361, "fiveYearAvgDividendYield": 2.14, "beta": 0.279, "trailingPE": 33.93478, "forwardPE": 18.921211, "volume": 5350, "regularMarketVolume": 5350, "averageVolume": 27000, "averageVolume10days": 31240, "averageDailyVolume10Day": 31240, "bid": 31.22, "ask": 31.26, "bidSize": 40000, "askSize": 40000, "marketCap": 34287052800, "fiftyTwoWeekLow": 17.1, "fiftyTwoWeekHigh": 31.89, "priceToSalesTrailing12Months": 0.01510733, "fiftyDayAverage": 29.12198, "twoHundredDayAverage": 23.342995, "trailingAnnualDividendRate": 120.0, "trailingAnnualDividendYield": 3.8498557, "currency": "USD", "enterpriseValue": -116354875392, "profitMargins": 0.06679, "floatShares": 395959852, "sharesOutstanding": 1080850048, "heldPercentInstitutions": 0.0034999999, "bookValue": 4641.145, "priceToBook": 0.0067267884, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "earningsQuarterlyGrowth": 0.419, "netIncomeToCommon": 151575003136, "trailingEps": 0.92, "forwardEps": 1.65, "enterpriseToRevenue": -0.051, "enterpriseToEbitda": -0.23, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "OTSKY", "underlyingSymbol": "OTSKY", "shortName": "Otsuka Holdings Co. Ltd.", "longName": "Otsuka Holdings Co., Ltd.", "firstTradeDateEpochUtc": 1344000600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "354dc656-fad8-3a75-9b4e-8d505e50ac41", "gmtOffSetMilliseconds": -18000000, "currentPrice": 31.22, "targetHighPrice": 37.47, "targetLowPrice": 37.47, "targetMeanPrice": 37.47, "targetMedianPrice": 37.47, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 1, "totalCash": 515110993920, "totalCashPerShare": 953.156, "ebitda": 505748324352, "totalDebt": 338986008576, "quickRatio": 1.326, "currentRatio": 1.921, "totalRevenue": 2269564108800, "debtToEquity": 13.288, "revenuePerShare": 2091.6016, "returnOnAssets": 0.071609996, "returnOnEquity": 0.06113, "earningsGrowth": 0.421, "revenueGrowth": 0.169, "grossMargins": 0.71422, "ebitdaMargins": 0.22284001, "operatingMargins": 0.22724001, "financialCurrency": "JPY", "trailingPegRatio": null, "__fetch_time": "2024-11-07"}]